|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
-0.31% | +19.70% |
| 08-10 | Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-03 | Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
Company Valuation: Cello Health plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 178.8 | 178.8 |
| Change | - | 0% |
| Enterprise Value (EV) 1 | 180.2 | 178.9 |
| Change | - | -0.72% |
| P/E | 43.4x | -109x |
| PBR | 1.51x | 2.55x |
| PEG | - | 1x |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | - | - |
| EV / EBIT | -1,820x | -10.8x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 0.0371 | -0.0147 |
| Distribution rate | - | - |
| Net sales | - | - |
| EBITDA | - | - |
| EBIT 1 | -0.099 | -16.5 |
| Net income 1 | 4.125 | -1.636 |
| Net Debt 1 | 1.341 | 0.042 |
| Reference price 2 | 1.610 | 1.610 |
| Nbr of stocks (in thousands) | 111,080 | 111,080 |
| Announcement Date | 8/11/26 | 8/11/26 |
1GBP in Million2GBP
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CLL Stock
- Valuation Cello Health plc
Select your edition
All financial news and data tailored to specific country editions
